ias - Monitoring
  • KI-Tools
  • Suche
  • Publizieren
  • Mediathek
Seite wählen

Bayer says to outsource some aspects of pharma business in Africa

von Tobias Borgers | Feb. 2, 2024 | Bayer

NAIROBI (Reuters) - Germany's Bayer will contract a third party to distribute its pharmaceutical products in four African markets including Kenya,...

mehr lesen

Durable Flooring for Life Science & Pharmaceuticals

von Tobias Borgers | Feb. 2, 2024 | Tablet Coating

Life science organizations and pharmaceutical companies operate in unique environments, where high-concentration chemicals, sensitive electronic...

mehr lesen

Olon eröffnet neue API-Anlage für hochwirksame pharmazeutische…

von Tobias Borgers | Feb. 2, 2024 | Fachzeitschriften

Sichere HPAPI-Handhabung Olon eröffnet neue API-Anlage für hochwirksame pharmazeutische Wirkstoffe Der API-Hersteller Olon Group hat den Bau einer...

mehr lesen

Boehringer Ingelheim setzt auf End-to-End-Datenökosystem

von Tobias Borgers | Jan. 19, 2024 | Boehringer

Klinische Studien, Biobank-Daten, elektronische Krankenakten, Lieferketten- und Produktionsdaten: In der Pharmabranche stehen unendlich viele Daten...

mehr lesen

Boehringer Ingelheim and 3T Biosciences enter into a second collaboration

von Tobias Borgers | Jan. 19, 2024 | Boehringer

INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 4, 2024 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and 3T Biosciences...

mehr lesen

Bayer and Sun Pharma sign marketing and distribution agreement

von Tobias Borgers | Jan. 19, 2024 | Bayer

Sun Pharmaceutical Industries Limited and Bayer on Thursday announced that both companies have signed an agreement to market and distribute a second...

mehr lesen

The Power of PAT in Pharmaceutical Manufacturing

von Tobias Borgers | Jan. 10, 2024 | Markt

The need for innovation in drug-making Introduction to PAT in pharmaceutical manufacturing Real-time monitoring and control Reducing variability and...

mehr lesen

Boehringer Ingelheim and 3T Biosciences enter into a second research partnership

von Tobias Borgers | Jan. 10, 2024 | Boehringer

INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 4, 2024 /PRNewswire/ -- Boehringer Ingelheim and 3T Biosciences ("3T") today announced they...

mehr lesen

GSK enters agreement to acquire Aiolos Bio

von Tobias Borgers | Jan. 10, 2024 | Glaxo

Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP...

mehr lesen

Digital Tech and Innovative Biomanufacturing

von Tobias Borgers | Jan. 3, 2024 | Markt

Digital technologies will help safeguard drug and vaccine supplies during health emergencies according to the European Medicines Agency (EMA), which...

mehr lesen
« Ältere Einträge
Nächste Einträge »
  • Backend
  • Alle Beiträge
  • Dokumentation
  • Logout